# Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

> **NCT05797077** · PHASE3 · RECRUITING · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 346 (estimated)

## Conditions studied

- Colorectal Cancer
- Liver Metastases
- Circulating Tumor Cell
- Cancer, Therapy-Related

## Interventions

- **PROCEDURE:** Colorectal resection surgery.
- **DRUG:** FOLFOX chemotherapy regimen
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT05797077
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-20
- **Primary completion:** 2029-02-20
- **Final completion:** 2031-02-20
- **Target enrollment:** 346 (ESTIMATED)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797077, "Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05797077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*